Edap Tms SA
NASDAQ:EDAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edap Tms SA
NASDAQ:EDAP
|
FR |
|
Z
|
Ziel Home Furnishing Technology Co Ltd
SZSE:301376
|
CN |
|
Tilaknagar Industries Ltd
NSE:TI
|
IN |
|
Sapporo Holdings Ltd
TSE:2501
|
JP |
|
Digital Holdings Inc
TSE:2389
|
JP |
|
K
|
KeyMed Biosciences Inc
HKEX:2162
|
CN |
|
Z
|
Zuger Kantonalbank
SIX:ZUGER
|
CH |
|
Shaftesbury Capital PLC
LSE:SHC
|
UK |
|
Sato Holdings Corp
TSE:6287
|
JP |
|
U
|
Uranium Energy Corp
AMEX:UEC
|
US |
|
I
|
Intercorp Financial Services Inc
NYSE:IFS
|
PE |
|
Sekisui House Reit Inc
TSE:3309
|
JP |
|
P
|
Playmates Holdings Ltd
HKEX:635
|
HK |
|
Usen Next Holdings Co Ltd
TSE:9418
|
JP |
|
G
|
Global Hydrogen SA
WSE:GHY
|
PL |
Edap Tms SA
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.
EDAP TMS SA is a holding company, which through its subsidiary engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. The company is headquartered in Vaulx-En-Velin, Auvergne-Rhone-Alpes and currently employs 227 full-time employees. The firm operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The firm invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The firm is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The firm is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
